Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE: Nursing Roles in Managing Patients With Gastroenteropancreatic Neuroendocrine Tumors
Clinical Journal of Oncology Nursing · 2024
DOI: 10.1188/24.cjon.79-87 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Journal of Oncology Nursing, 2024. Verfasst von Bonita Bennett und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Pennsylvania. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Organometallic Compounds, Pancreatic Neoplasms, Intestinal Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Pennsylvania.
- University of California, Los Angeles.
- Ochsner Medical Center.
Zitieren
APA
Bennett, B., Gardner, L., & Ryan, P. (2024). Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE: Nursing Roles in Managing Patients With Gastroenteropancreatic Neuroendocrine Tumors. Clinical Journal of Oncology Nursing. https://doi.org/10.1188/24.cjon.79-87
Vancouver
Bennett B, Gardner L, Ryan P. Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE: Nursing Roles in Managing Patients With Gastroenteropancreatic Neuroendocrine Tumors. Clinical Journal of Oncology Nursing. 2024. doi:10.1188/24.cjon.79-87
BibTeX
@article{Bennett2024,
author = {Bennett, Bonita and Gardner, Linda and Ryan, Pamela},
title = {Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE: Nursing Roles in Managing Patients With Gastroenteropancreatic Neuroendocrine Tumors},
journal = {Clinical Journal of Oncology Nursing},
year = {2024},
doi = {10.1188/24.cjon.79-87}
}
EUVIMED